: The long-term objectives to which the proposed studies relate are to identify and evaluate natural processes that regulate immune responsiveness towards tissue allografts, tumors and cells infected with pathogenic organisms. The specific goal of the studies proposed is to evaluate the role of cells expressing indoleamine 2,3 dioxygenase (IDO), which catabolizes tryptophan, in suppressing T cell mediated immunity directed against allogeneic tissues and tumor cells. The hypothesis to which these studies relate is that cells expressing IDO suppress or modify T cell responsiveness providing increased protection against T cell mediated immunity for cells in local tissue microenvironments. We will also conduct experiments to evaluate mechanistic links between T cell and complement activation that are suppressed by IDO activity in local tissue microenvironments. To evaluate the role of IDO in inflammation and immunosuppression we will utilize two new strains of genetically-manipulated mice generated recently in our laboratory. We will measure inflammatory and T cell responses in mice that do not express IDO (IDO-deficient mice) and in transgenic mice that over-express IDO in response to inflammatory signals (MHCII-IDO mice).
In Aim 1 we will test the hypothesis that targeted deletion of IDO leads to enhanced accessory and antigen-presenting cell functions for T cell and complement activation and targeted IDO over-expression suppresses T cell and complement activation.
In Aim 2 we will evaluate pregnancy outcomes for allogeneic and syngeneic fetuses in matings between parents that carry defective IDO alleles.
In Aim 3 we will evaluate immune responses to tissue allografts from IDO-deficient and MHCII-IDO recipient and donor mice.
In Aim 4 we will test the hypothesis that IDO activity suppresses host anti-tumor immunity. Data obtained from these studies will reveal the extent to which IDO activity in local tissue microenvironments influences T cell activation and elucidate the mechanism by which T cell driven complement deposition occurs in pregnant and tumor-bearing mice when IDO activity is blocked. Knowledge gained from the proposed studies will allow us to evaluate the potential for adapting the IDO immunosuppressive mechanism to facilitate tissue allograft acceptance and develop novel therapeutic strategies to help eradicate tumors in immunocompetent hosts.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD041187-05
Application #
7034646
Study Section
Immunobiology Study Section (IMB)
Program Officer
Coulombe, James N
Project Start
2002-04-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2008-03-31
Support Year
5
Fiscal Year
2006
Total Cost
$315,288
Indirect Cost
Name
Georgia Health Sciences University
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Sharma, Madhav D; Huang, Lei; Choi, Jeong-Hyeon et al. (2013) An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity 38:998-1012
Divanovic, Senad; Sawtell, Nancy M; Trompette, Aurelien et al. (2012) Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis 205:152-61
Li, Lingqian; Huang, Lei; Lemos, Henrique P et al. (2012) Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases. Front Immunol 3:109
Medzhitov, Ruslan; Shevach, Ethan M; Trinchieri, Giorgio et al. (2011) Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol 11:693-702
Parolini, O; Alviano, F; Betz, A G et al. (2011) Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS). Placenta 32 Suppl 4:S285-90
Baban, Babak; Chandler, Phillip R; Johnson 3rd, Burles A et al. (2011) Physiologic control of IDO competence in splenic dendritic cells. J Immunol 187:2329-35
Lanz, Tobias V; Opitz, Christiane A; Ho, Peggy P et al. (2010) Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Stem Cells Dev 19:657-68
Sharma, Madhav D; Hou, De-Yan; Baban, Babak et al. (2010) Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. Immunity 33:942-54
Johnson 3rd, Burles A; Kahler, David J; Baban, Babak et al. (2010) B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase. Proc Natl Acad Sci U S A 107:10644-8
Wang, Yutang; Liu, Hanzhong; McKenzie, Gavin et al. (2010) Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 16:279-85

Showing the most recent 10 out of 28 publications